Found: 8
Select item for more details and to access through your institution.
Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis.
- Published in:
- Hepatology Research, 2009, v. 39, n. 5, p. 432, doi. 10.1111/j.1872-034X.2008.00477.x
- By:
- Publication type:
- Article
Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine.
- Published in:
- Hepatology Research, 2008, v. 38, n. 5, p. 450, doi. 10.1111/j.1872-034X.2007.00292.x
- By:
- Publication type:
- Article
Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C.
- Published in:
- Hepatology Research, 2008, v. 38, n. 1, p. 52, doi. 10.1111/j.1872-034X.2007.00205.x
- By:
- Publication type:
- Article
Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
- Published in:
- Hepatology Research, 2006, v. 35, n. 3, p. 185, doi. 10.1016/j.hepres.2006.03.008
- By:
- Publication type:
- Article
Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control study.
- Published in:
- Journal of Gastroenterology, 2011, v. 46, n. 11, p. 1335, doi. 10.1007/s00535-011-0455-1
- By:
- Publication type:
- Article
Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance.
- Published in:
- Journal of Gastroenterology, 2009, v. 44, n. 8, p. 864, doi. 10.1007/s00535-009-0076-0
- By:
- Publication type:
- Article
Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B.
- Published in:
- Journal of Gastroenterology, 2009, v. 44, n. 6, p. 601, doi. 10.1007/s00535-009-0038-6
- By:
- Publication type:
- Article
Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C.
- Published in:
- Journal of Gastroenterology, 2006, v. 41, n. 9, p. 862, doi. 10.1007/s00535-006-1858-2
- By:
- Publication type:
- Article